Feb 27 (Reuters) - BioDelivery Sciences International Inc
 BDSI.O :
    * BIODELIVERY SCIENCES ANNOUNCES PHASE I CLINICAL TRIAL
RESULTS AT
THE AMERICAN ACADEMY OF PAIN MEDICINE’S 36TH ANNUAL MEETING
    * BIODELIVERY SCIENCES - IMMEDIATE RELEASE ORAL OXYCODONE
HCL
ASSOCIATED WITH A DOSE-DEPENDENT DECREASE IN RESPIRATORY DRIVE
COMPARED TO PLACEBO

Source text for Eikon:  ID:nGNX7LPV0k 
Further company coverage:  BDSI.O 

 ((Reuters Messaging: Reuters.Briefs@thomsonreuters.com))